Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Stephan Matthaei

Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-On to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Related publications

Triple Therapy With Low‐Dose Dapagliflozin Plus Saxagliptin Versus Dual Therapy With Each Monocomponent, All Added to Metformin, in Uncontrolled Type 2 Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Effect of Adding Insulin Degludec to Treatment in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Liraglutide: A Double-Blind Randomized Controlled Trial (BEGIN: ADD TO GLP-1 Study)

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Efficacy and Safety of Ipragliflozin Add‐on Therapy to Insulin in Japanese Patients With Type 1 Diabetes Mellitus: A Randomized, Double‐blind, Phase 3 Trial

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2018English

Dapagliflozin: Cost-Effectiveness as an Add-On Therapy to Metformin in the Treatment of Type 2 Diabetes (T2DM) in Argentina and Chile

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Efficacy and Safety of Once-Weekly Semaglutide Versus Daily Canagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes (SUSTAIN 8): A Double-Blind, Phase 3b, Randomised Controlled Trial

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Effect of Linagliptin and Voglibose on Metabolic Profile in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

BMC pharmacology & toxicology
MedicinePharmacology
2018English

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy